EPTIFIBATIDE INJECTION
Google image searchProduct monograph
Active ingredient
eptifibatide, 0.75 MG/ML
DIN: 02540819
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: JUNO PHARMACEUTICALS CORP.
Date: 16-MAY-2024
ATC:
- B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
- B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
- B01AC — Platelet aggregation inhibitors excl. heparin (ATC, ATC/DDD)
- B01AC16 — EPTIFIBATIDE (ATC/DDD)
Reference brand drug: Integrilin
